Fennec Pharmaceuticals (FENC)

• Market cap: $335M
• 1 day: 0%
• 5 days: -5.95%
• 1 month: -10.23%
• 3 months: 48.69%
• 6 months: 27.14%
• Year to date: 25.65%
• 1 year: 14.74%
• 5 years: 48.23%
• 10 years: -19.58%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 35